Ascend Wellness Holdings (AAWH) Total Non-Current Liabilities (2021 - 2026)

Ascend Wellness Holdings' (AAWH) quarterly Total Non-Current Liabilities came in at $27.6 million in Q1 2026, up 37.32% year-on-year from $20.1 million in Q1 2025, and up 24.62% quarter-over-quarter from $22.1 million in Q4 2025.

Ascend Wellness Holdings (AAWH) Total Non-Current Liabilities (2021 - 2026) Analysis & Trends

Ascend Wellness Holdings' Total Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $27.6 million for Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities rose 37.32% year-over-year to $27.6 million in Q1 2026; TTM through Mar 2026 was $27.6 million, a 37.32% increase from a year earlier, with the FY2025 full-year figure at $22.1 million, up 59.01% from the prior year.
  • Total Non-Current Liabilities grew to $27.6 million in Q1 2026 per AAWH's latest filing, from $22.1 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $717.5 million in Q2 2023 and bottomed at $9.3 million in Q1 2024.
  • The 5-year median for Total Non-Current Liabilities is $20.7 million (2025), against an average of $123.1 million.
  • Across the five-year window, Total Non-Current Liabilities surged 523.93% in 2023 and plunged 98.69% in 2024, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $115.0 million in 2022, then slumped by 91.73% to $9.5 million in 2023, then jumped by 46.3% to $13.9 million in 2024, then surged by 59.01% to $22.1 million in 2025, then climbed by 24.62% to $27.6 million in 2026.
  • Per Business Quant, the three latest AAWH Total Non-Current Liabilities figures stand at $27.6 million (Q1 2026), $22.1 million (Q4 2025), and $26.4 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 14.92 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 18.28 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 11.64 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 33.47 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 20.09 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.24 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.26 Bn
10 Ascend Wellness Holdings 83.00 Mn 22.91 Mn 44.88 Mn 27.59 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 27.59 Mn
Dec 31, 2025 22.14 Mn
Sep 30, 2025 26.42 Mn
Jun 30, 2025 21.27 Mn
Mar 31, 2025 20.09 Mn
Dec 31, 2024 13.92 Mn
Sep 30, 2024 13.42 Mn
Jun 30, 2024 11.85 Mn
Mar 31, 2024 9.28 Mn
Dec 31, 2023 9.52 Mn
Sep 30, 2023 9.52 Mn
Jun 30, 2023 717.54 Mn
Mar 31, 2023 705.56 Mn
Jun 30, 2022 115.00 Mn
Dec 31, 2021 126.40 Mn